Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01873924 · ClinicalTrials.gov registry record
Clinical and Neuropsychological Investigations in Batten Disease
A clinical trial of Batten Disease and Neuronal Ceroid Lipofuscinosis, sponsored by University of Rochester.
- Recruiting
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT01873924: Recruiting study of Batten Disease and Neuronal Ceroid Lipofuscinosis, sponsored by University of Rochester.
NCT01873924 is a study of Batten Disease and Neuronal Ceroid Lipofuscinosis that is actively recruiting participants, run by University of Rochester. The registered enrollment target is 500 participants, below the 2,784-participant average among 11 other Batten Disease trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01873924, a study of Batten Disease and Neuronal Ceroid Lipofuscinosis, is actively recruiting participants, sponsored by University of Rochester.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to assess the natural history of Batten disease (Neuronal Ceroid Lipofuscinosis) by obtaining information about the motor, behavioral, and functional capabilities of individuals with Batten disease. This study will also refine and validate the Unified Batten Disease Rating Scale (UBDRS) as a clinical rating instrument for Batten disease.
Primary Outcome
A quantitative measure of natural history
Conditions Studied
Study Locations (1)
New York
- University of Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2004-08 |
| Est. Completion | 2035-08 |
What NCT01873924 shows while recruiting
NCT01873924 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 2,784-participant average among 11 other Batten Disease trials with a reported enrollment target (82% lower).
The record links to 10 conditions, with Batten Disease appearing as the primary indexed condition, and to 0 interventions.
NCT01873924 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01873924 about?
NCT01873924 is a clinical study titled "Clinical and Neuropsychological Investigations in Batten Disease". This study aims to assess the natural history of Batten disease (Neuronal Ceroid Lipofuscinosis) by obtaining information about the motor, behavioral, and functional capabilities of individuals with Batten disease. This study will also refine and validate the Unified Batten Disease Rating Scale (UBD...
What is the current status of trial NCT01873924?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2004-08. Estimated completion is 2035-08.
What conditions does trial NCT01873924 study?
This clinical trial studies the following conditions: Batten Disease, Neuronal Ceroid Lipofuscinosis, Neuronal Ceroid Lipofuscinosis CLN5, Neuronal Ceroid Lipofuscinosis CLN1, Neuronal Ceroid Lipofuscinosis CLN2.
Who is sponsoring clinical trial NCT01873924?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01873924 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Batten Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01873924's enrollment target sits among peer trials
500 3rd of 11 higher than 9 of 11 other Batten Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Batten Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Inherited Retinal Degenerative Disease Registry
RECRUITING
-
NYSCF Scientific Discovery Biobank
RECRUITING
-
UCB Transplant of Inherited Metabolic Diseases With Administration of Intrathecal UCB Derived Oligodendrocyte-Like Cells
RECRUITING · Phase 1
-
Investigations of Juvenile Neuronal Ceroid Lipofuscinosis
RECRUITING
-
Long-Term Follow Up of CLN6 Batten Disease Subjects Following Gene Transfer
ACTIVE NOT RECRUITING
-
Gene Therapy for Children With CLN3 Batten Disease
ACTIVE NOT RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia